1. Home
  2. FBK vs VERA Comparison

FBK vs VERA Comparison

Compare FBK & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FB Financial Corporation

FBK

FB Financial Corporation

HOLD

Current Price

$54.32

Market Cap

2.8B

Sector

Finance

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$35.25

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBK
VERA
Founded
1906
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.2B
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
FBK
VERA
Price
$54.32
$35.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
10
Target Price
$64.50
$81.30
AVG Volume (30 Days)
262.9K
1.1M
Earning Date
04-13-2026
05-06-2026
Dividend Yield
1.56%
N/A
EPS Growth
N/A
N/A
EPS
2.45
N/A
Revenue
N/A
N/A
Revenue This Year
$41.72
N/A
Revenue Next Year
$7.21
$472.48
P/E Ratio
$22.10
N/A
Revenue Growth
N/A
N/A
52 Week Low
$42.29
$18.76
52 Week High
$62.37
$56.05

Technical Indicators

Market Signals
Indicator
FBK
VERA
Relative Strength Index (RSI) 51.84 30.97
Support Level $52.27 $22.10
Resistance Level $54.84 $42.77
Average True Range (ATR) 1.35 1.88
MACD 0.00 -0.68
Stochastic Oscillator 41.78 5.44

Price Performance

Historical Comparison
FBK
VERA

About FBK FB Financial Corporation

FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates majority of revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: